Mwangi Benson, Spiker Danielle, Zunta-Soares Giovana B, Soares Jair C
Department of Psychiatry and Behavioral Sciences, University of Texas Center of Excellence on Mood Disorders, UT Houston Medical School, Houston, TX, USA.
Bipolar Disord. 2014 Nov;16(7):713-21. doi: 10.1111/bdi.12222. Epub 2014 Jun 11.
Pediatric bipolar disorder is currently diagnosed based on signs and symptoms, and without objective diagnostic biomarkers. In the present study, we investigated the utility of structural neuroanatomical signatures of the amygdala to objectively differentiate individual subjects with pediatric bipolar disorder from matched healthy controls.
Structural T1 -weighted neuroimaging scans were obtained from 16 children and adolescents with unmedicated DSM-IV bipolar disorder (11 males, five females) and 16 matched healthy controls (11 males, five females). Voxel-based gray matter morphometric features extracted from a bilateral region-of-interest within the amygdala were used to develop a multivariate pattern analysis model which was utilized in predicting novel or 'unseen' individual subjects as either bipolar disorder or healthy controls.
The model assigned 25 out of 32 subjects the correct label (bipolar disorder/healthy) translating to a 78.12% diagnostic accuracy, 81.25% sensitivity, 75.00% specificity, 76.47% positive predictive value, and 80.00% negative predictive value and an area under the receiver operating characteristic curve (ROC) of 0.81. The predictions were significant at p = 0.0014 (χ(2) test p-value).
These results reaffirm previous reports on the existence of neuroanatomical abnormalities in the amygdala of pediatric patients with bipolar disorder. Remarkably, the present study also demonstrates that neuroanatomical signatures of the amygdala can predict individual subjects with bipolar disorder with a relatively high specificity and sensitivity. To the best of our knowledge, this is the first study to present a proof-of-concept diagnostic marker of pediatric bipolar disorder based on structural neuroimaging scans of largely medication-naïve patients.
儿童双相情感障碍目前是根据体征和症状进行诊断的,且没有客观的诊断生物标志物。在本研究中,我们调查了杏仁核的结构神经解剖学特征在客观区分患有儿童双相情感障碍的个体与匹配的健康对照方面的效用。
对16名未用药的DSM-IV双相情感障碍儿童和青少年(11名男性,5名女性)以及16名匹配的健康对照(11名男性,5名女性)进行了结构性T1加权神经影像扫描。从杏仁核内双侧感兴趣区域提取的基于体素的灰质形态学特征被用于开发一个多变量模式分析模型,该模型用于预测新的或“未见过”的个体是双相情感障碍患者还是健康对照。
该模型在32名受试者中为25名分配了正确的标签(双相情感障碍/健康),诊断准确率为78.12%,灵敏度为81.25%,特异度为75.00%,阳性预测值为76.47%,阴性预测值为80.00%,受试者工作特征曲线(ROC)下面积为0.81。预测在p = 0.0014时具有显著性(χ(2)检验p值)。
这些结果再次证实了先前关于患有双相情感障碍的儿科患者杏仁核存在神经解剖学异常的报道。值得注意的是,本研究还表明,杏仁核的神经解剖学特征可以以相对较高的特异度和灵敏度预测双相情感障碍个体。据我们所知,这是第一项基于对基本未用药患者的结构神经影像扫描提出儿童双相情感障碍概念验证诊断标志物的研究。